Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling
Cinobufagin may attenuate the PI3K/AKT-dependent metastatic potential of hepatocellular carcinoma by inhibiting the VEGFa/VEGFR2 autocrine pathway.
Authors
- BAI-KUN LI (ORCID: https://orcid.org/0000-0001-5724-600X)
- Ji‐Min Zhu (ORCID: https://orcid.org/0000-0001-5773-0790)
- Mingjun Ye
- Jiaming Tian (ORCID: https://orcid.org/0000-0003-0688-6757)
- Lu Chen (ORCID: https://orcid.org/0000-0002-6208-1438)
- Qinglin Li (ORCID: https://orcid.org/0000-0002-4475-7158)
- Shujun Chen (ORCID: https://orcid.org/0000-0003-4642-3087)
- Anjia Han (ORCID: https://orcid.org/0000-0003-2245-1972)
- Ying Wu (ORCID: https://orcid.org/0000-0002-4939-4552)
Institutions
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1007/s12672-025-02707-9
- Citations
- 2
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- Anhui University
- Anhui University of Chinese Medicine
- Natural Science Foundation of Anhui Province